PTC Therapeutics Inc (NAS:PTCT)
$ 44.16 -0.46 (-1.03%) Market Cap: 3.41 Bil Enterprise Value: 2.83 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

PTC Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 12:30PM GMT
Release Date Price: $66.27 (-1.94%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Good morning, and welcome to the 39th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. I want to thank everyone for logging in and joining us this week.

Our first presenting company this morning is PTC Therapeutics. It is my pleasure to welcome and introduce Stuart Peltz to tell us a little bit about the company.

A quick formatting note. There is a Q&A session after Stu's presentation. (Operator Instructions)

With that, Stu, let me pass it over to you for the presentation.

Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director

Yes. Thanks, Eric. Thanks, everyone. Welcome. Thanks for coming today. As shown on Slide 2 in our presentation, we'll be making some forward-looking statements, so I want to refer you to our SEC filings.

So as on Slide 3, I'm going to tell you today about how we're translating science to transform lives. And if you go to Slide 4, I think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot